🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.230
-0.120 (-5.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Sunshine Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
35.3736.3134.8724.094.350.23
Revenue Growth
-5.23%4.11%44.75%454.42%1802.41%219.88%
Cost of Revenue
24.6324.0524.215.752.650.12
Gross Profit
10.7412.2610.678.341.70.11
Selling, General & Admin
15.7215.3314.9410.839.481.87
Research & Development
0.120.60.931.860.810.67
Other Operating Expenses
0.530.470.390.290.06-
Operating Expenses
16.716.7316.4813.1210.372.55
Operating Income
-5.96-4.48-5.81-4.79-8.67-2.44
Interest Expense
---0.01-0.14-0.04-0.33
Interest & Investment Income
0.230.280.50.810.52-
Currency Exchange Gain (Loss)
-0.050-0.04-0-00
Other Non Operating Income (Expenses)
0.1-----
EBT Excluding Unusual Items
-5.67-4.2-5.37-4.11-8.2-2.77
Impairment of Goodwill
-----18.33-
Gain (Loss) on Sale of Assets
-0.03-0.01----
Asset Writedown
-0.13-1.75----
Other Unusual Items
----0.01-9.67
Pretax Income
-5.83-5.95-5.37-4.11-26.51-12.44
Income Tax Expense
0.340.02-0.230.40.23-
Earnings From Continuing Operations
-6.17-5.98-5.13-4.51-26.74-12.44
Net Income
-6.17-5.98-5.13-4.51-26.74-12.44
Net Income to Common
-6.17-5.98-5.13-4.51-26.74-12.44
Net Income Growth
------
Shares Outstanding (Basic)
00----
Shares Outstanding (Diluted)
00----
Shares Change
592.59%-----
EPS (Basic)
-51.23-287.48----
EPS (Diluted)
-51.23-287.48----
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-6.01-5.51-14.18-8.86-5.44-1.83
Free Cash Flow Per Share
-49.87-264.88----
Gross Margin
30.36%33.76%30.59%34.61%39.04%48.42%
Operating Margin
-16.84%-12.34%-16.67%-19.86%-199.61%-1068.24%
Profit Margin
-17.45%-16.46%-14.72%-18.70%-615.44%-5444.41%
Free Cash Flow Margin
-16.98%-15.16%-40.67%-36.76%-125.24%-800.75%
EBITDA
-5.63-4.15-5.59-4.64-8.65-2.43
EBITDA Margin
-15.91%-11.42%-16.02%-19.24%-199.03%-
D&A For EBITDA
0.330.330.220.150.030.01
EBIT
-5.96-4.48-5.81-4.79-8.67-2.44
EBIT Margin
-16.84%-12.34%-16.67%-19.86%-199.61%-
SEC Filings: 10-K · 10-Q